about
Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasActivation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Whole-genome fingerprint of the DNA methylome during human B cell differentiation.Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.CCAAT/enhancer binding protein alpha (C/EBP(alpha))-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation.DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights.CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells.Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.The involvement of the transcription factor Yin Yang 1 in cancer development and progression.Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation.Progesterone receptor induces bcl-x expression through intragenic binding sites favoring RNA polymerase II elongation.Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.Nucleosome-driven transcription factor binding and gene regulation.Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension.Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.Non-coding recurrent mutations in chronic lymphocytic leukaemiaDNA methylation fingerprint of neuroblastoma reveals new biological and clinical insightsNew potential ligand-receptor signaling loops in ovarian cancer identified in multiple gene expression studiesCyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasmsAndrogen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
P50
Q28475549-4BB60307-F743-4FCF-9D03-A65376056E79Q33699139-CA29FC13-C8E5-4CA7-B82C-EF7C44E52426Q33727500-D2F1808B-C7E6-4192-BD17-30BF5735009DQ33762936-0AC871EE-2F79-4819-8080-0709A732B271Q34460989-7AD6C658-5370-402D-9FEF-ED69796E5657Q35345851-F797837A-5DCA-4B45-8EA5-04631D6DC908Q36094545-5EC0A11F-3E8A-4132-BB0F-04321B3CFD4CQ36213722-8836C83A-1ABB-4C77-91E3-A6BAB594B62BQ36410154-29F5884D-4905-456D-B615-ACFCA9D6025CQ36982136-E06BA706-C215-4A70-8AFE-E2370160008AQ37431346-C3C9EB80-B1D7-4F1D-9B37-FC422FA2E31DQ38951482-4DF8430F-FE08-4477-A40A-23E74FAD33EDQ39156822-37F8D2A5-15EA-4E30-B4F0-21DEC5619B53Q39162952-3C265BAB-FEBA-4193-AE47-C5D4EA7C7CCEQ39210058-44EF5016-561F-448A-ABBA-B264E281CECCQ39239873-0C87380F-1C8B-4686-ABEA-72BD4D2F8D20Q39499581-96807CDF-17FC-4843-A6A1-46524D8E5A32Q39568693-3CD64250-C549-4EBB-A8E9-3952ABDE34DFQ39726414-67E57266-CA2D-4A33-8B6F-6B3E581DE04BQ40527877-2F740E3A-E0D7-4755-A893-6FB6D8700160Q48284944-C6FB928B-B451-4A4D-9011-48999C8C50F0Q50784932-C45932AD-8B8D-417C-A294-65840D32F526Q50932977-1B3F2D33-A6CD-42FB-A039-18FF6EE79A13Q54788220-EE33705D-63F5-416F-B28C-A1D4FCB466B8Q56996904-DAC3FBC9-281F-4062-AFF4-62ACF58265BBQ61311979-CFF45A64-C73F-4F0B-8E6F-F57E836BCC26Q79337025-B5FA3516-0838-46C4-A7B5-16B3B30F3D3AQ89498262-66AC8E7A-C8EF-4646-9806-09A6490453DDQ92702546-F818EA44-CAEF-40B9-8E3F-A7A465F6B549
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Giancarlo Castellano
@ast
Giancarlo Castellano
@en
Giancarlo Castellano
@es
Giancarlo Castellano
@nl
Giancarlo Castellano
@sl
type
label
Giancarlo Castellano
@ast
Giancarlo Castellano
@en
Giancarlo Castellano
@es
Giancarlo Castellano
@nl
Giancarlo Castellano
@sl
prefLabel
Giancarlo Castellano
@ast
Giancarlo Castellano
@en
Giancarlo Castellano
@es
Giancarlo Castellano
@nl
Giancarlo Castellano
@sl
P214
P106
P21
P214
P31
P396
IT\ICCU\CFIV\253661
P496
0000-0002-5715-7733
P734
P735
P7859
viaf-307337249